West Pharmaceutical Services Income After Taxes 2010-2024 | WST

West Pharmaceutical Services annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
  • West Pharmaceutical Services income after taxes for the quarter ending September 30, 2024 was $0.132B, a 16.18% decline year-over-year.
  • West Pharmaceutical Services income after taxes for the twelve months ending September 30, 2024 was $0.484B, a 10.74% decline year-over-year.
  • West Pharmaceutical Services annual income after taxes for 2023 was $0.576B, a 1.86% increase from 2022.
  • West Pharmaceutical Services annual income after taxes for 2022 was $0.565B, a 11.92% decline from 2021.
  • West Pharmaceutical Services annual income after taxes for 2021 was $0.642B, a 95.16% increase from 2020.
West Pharmaceutical Services Annual Income After Taxes
(Millions of US $)
2023 $576
2022 $565
2021 $642
2020 $329
2019 $233
2018 $199
2017 $142
2016 $135
2015 $90
2014 $122
2013 $107
2012 $76
2011 $69
2010 $61
2009 $70
West Pharmaceutical Services Quarterly Income After Taxes
(Millions of US $)
2024-09-30 $132
2024-06-30 $107
2024-03-31 $111
2023-12-31 $134
2023-09-30 $158
2023-06-30 $150
2023-03-31 $134
2022-12-31 $100
2022-09-30 $116
2022-06-30 $183
2022-03-31 $167
2021-12-31 $148
2021-09-30 $169
2021-06-30 $179
2021-03-31 $146
2020-12-31 $95
2020-09-30 $77
2020-06-30 $86
2020-03-31 $72
2019-12-31 $61
2019-09-30 $54
2019-06-30 $64
2019-03-31 $54
2018-12-31 $51
2018-09-30 $53
2018-06-30 $54
2018-03-31 $41
2017-12-31 $-3
2017-09-30 $49
2017-06-30 $38
2017-03-31 $57
2016-12-31 $37
2016-09-30 $35
2016-06-30 $43
2016-03-31 $21
2015-12-31 $31
2015-09-30 $-0
2015-06-30 $27
2015-03-31 $32
2014-12-31 $30
2014-09-30 $30
2014-06-30 $36
2014-03-31 $26
2013-12-31 $23
2013-09-30 $25
2013-06-30 $29
2013-03-31 $31
2012-12-31 $21
2012-09-30 $13
2012-06-30 $14
2012-03-31 $28
2011-12-31 $17
2011-09-30 $15
2011-06-30 $18
2011-03-31 $18
2010-12-31 $5
2010-09-30 $17
2010-06-30 $20
2010-03-31 $19
2009-12-31 $19
2009-09-30 $16
2009-06-30 $19
2009-03-31 $15
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.723B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.143B 21.32
Becton Dickinson (BDX) United States $67.812B 17.83
Cardinal Health (CAH) United States $29.438B 15.96
Cooper (COO) United States $20.623B 29.35
Labcorp (LH) United States $20.401B 16.92
Align Technology (ALGN) United States $16.815B 32.18
Henry Schein (HSIC) United States $8.514B 16.22
Merit Medical Systems (MMSI) United States $6.067B 30.98
DENTSPLY SIRONA (XRAY) United States $3.508B 9.54
CONMED (CNMD) United States $2.312B 19.29
Patterson (PDCO) United States $1.855B 9.79
STAAR Surgical (STAA) United States $1.499B 55.31
Lifevantage (LFVN) United States $0.176B 23.40
Pro-Dex (PDEX) United States $0.154B 30.74